Clinical Research
Copyright ©The Author(s) 2005.
World J Gastroenterol. Aug 21, 2005; 11(31): 4833-4837
Published online Aug 21, 2005. doi: 10.3748/wjg.v11.i31.4833
Table 2 Distributions of six NAT2-haplotypes in patients with UC/CD and controls
HaplotypeSNPNumber (%) of subjects with haplotype
UC (allele = 190)CD (allele = 120)Control (allele = 400)
NAT2*4None122 (64.2)77 (64.2)278 (69.5)
NAT2*5BT341C, C481T, A803G3 (1.6)1 (0.8)2 (0.5)
NAT2*6AC282T, G590A43 (22.6)21 (17.5)79 (19.75)
NAT2*7BC282T, G857A20 (10.5)18 (15.0)35 (8.75)
NAT2*11C481T0 (0)1 (0.8)1 (0.25)
NAT2*13C282T2 (1.1)2 (1.7)5 (1.25)